Improving comorbid ACS and Type 2 diabetes management
Research type
Research Study
Full title
Improving comorbid acute coronary syndrome and type 2 diabetes management: identifying an optimal shared pathway
IRAS ID
318095
Contact name
Karen McGuigan
Contact email
Sponsor organisation
Queen's University Belfast
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
Background:
Acute coronary syndrome (ACS) and Type 2 diabetes (T2D) commonly present together (comorbid conditions). However, current guidelines for ACS and T2D care address individual conditions, leaving care for comorbid ACS/T2D fragmented and poorly organised, impacting effective condition management.
Aim:
To identify how comorbid ACS and T2D are managed across time at individual, primary and secondary care levels to develop an optimal shared care pathway
Methods:
A three-stage study will be conducted.
Stage 1 will examine the current basis for practice via: review of existing practice guidelines, and scoping review exploring strengths and weaknesses in current provisions on integrated care and condition management for those with comorbid ACS or T2D
Stage 2 will use qualitative approach to investigate comorbid ACS/T2D management from the perspective of those living with both conditions and aligned healthcare professionals. Twenty patients with comorbid ACS/T2D will be recruited. Patient perspectives will be explored longitudinally via interview, text message/telephone call survey and focus group. Views of relevant healthcare professionals will be captured via focus group interviews.
Information from Stage 1 and 2 will be amalgamated to inform a prototype optimal pathway of care for
those with comorbid ACS/T2D.
Stage 3 will involve convening of a symposium, providing a public forum to disseminate and discuss study findings, suggest modifications and seek agreement on the prototype pathway.
Impact:
This study will develop a prototype optimal shared care pathway informed by best-practice guidelines, patient need and clinical expertise. Prototype pathway will offer a basis to streamline provision, improve outcomes and reduce health service dependency among those with comorbid ACS/T2D in Northern Ireland.REC name
East Midlands - Nottingham 2 Research Ethics Committee
REC reference
22/EM/0241
Date of REC Opinion
9 Nov 2022
REC opinion
Further Information Favourable Opinion